We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

In-Hospital Cardiac Arrest in China: Incidence, Care Processes, and Survival Outcomes in a Multicenter Prospective Study

MedXY Editorial Team•Oct 10, 2026•Cardiology
ChinaIHCAIn-hospital cardiac arrestresuscitationsurvival outcomes

Highlight

This large multicenter prospective registry documented the incidence of adult in-hospital cardiac arrest (IHCA) across China, revealing a notable patient burden with an annual incidence of 4.1 per 1000 admissions and a low overall survival rate of 9.1% to 30 days or hospital discharge. The study identified rapid initial resuscitation times but uncovered significant gaps in the application of advanced postresuscitation therapies such as temperature control and coronary angiography. Furthermore, systemic and cultural obstacles including the rarity of do-not-attempt-resuscitation (DNACPR) orders were suggested as contributors to suboptimal long-term outcomes.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Complete Surgical Resection Enhances Survival in High-Risk Neuroblastoma: Insights from COG ANBL0532 TrialComplete resection of the primary tumor significantly improves survival outcomes and reduces local progression without increasing surgical complications in high-risk neuroblastoma patients.Oct 11, 2026Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working PartyThis retrospective study evaluates survival outcomes and risk factors associated with allogeneic hematopoietic cell transplantation in young adults (18-40 years) with myelodysplastic syndrome, revealing encouraging survival rates and highliOct 8, 2026Ovarian-Sparing Surgery in Early-Stage Adult Granulosa Cell Tumors: Comparable Survival Outcomes to Bilateral OophorectomyThis study demonstrates that ovarian-sparing surgery in premenopausal patients with early-stage adult granulosa cell tumors offers survival outcomes similar to bilateral salpingo-oophorectomy, supporting fertility-preserving options in clinOct 6, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Lidocaine Versus Amiodarone for Refractory Ventricular Fibrillation in Adult In-Hospital Cardiac Arrest: Evidence from a Nationwide Chinese Registry
A nationwide prospective study shows no significant difference in survival or neurological outcomes between lidocaine and amiodarone for adult in-hospital cardiac arrest patients with refractory ventricular fibrillation or pulseless ventric
Sep 30, 2026
Contemporary Surgical Management of Vulvar Cancer: Balancing Improved Survival with Increased Reoperation Rates — Insights from a Finnish Nationwide StudyThis review synthesizes evidence that modern personalized surgical strategies for vulvar squamous cell carcinoma enhance survival outcomes despite higher reoperation rates, emphasizing evolving surgical techniques, sentinel lymph node biopsSep 27, 2026
Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple MyelomaMaintenance therapies—lenalidomide, thalidomide, and bortezomib—significantly improve survival after autologous stem cell transplant for multiple myeloma, regardless of initial response status, based on a large global registry analysis.Sep 22, 2026